113 related articles for article (PubMed ID: 3311346)
1. ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas.
Czerniak B; Herz F; Koss LG; Schlom J
Cancer; 1987 Nov; 60(10):2432-6. PubMed ID: 3311346
[TBL] [Abstract][Full Text] [Related]
2. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia.
Czerniak B; Herz F; Gorczyca W; Koss LG
Cancer; 1989 Oct; 64(7):1467-73. PubMed ID: 2550123
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions.
Nakajima K; Kuzumaki N; Oda A; Kobayashi H; Katoh H; Tanabe T
Oncology; 1989; 46(4):260-5. PubMed ID: 2662090
[TBL] [Abstract][Full Text] [Related]
5. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5.
Lanza G
Histopathology; 1988 Jun; 12(6):595-609. PubMed ID: 3047043
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
Nakajima K
Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
[TBL] [Abstract][Full Text] [Related]
7. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers.
Noguchi M; Hirohashi S; Shimosato Y; Thor A; Schlom J; Tsunokawa Y; Terada M; Sugimura T
J Natl Cancer Inst; 1986 Aug; 77(2):379-85. PubMed ID: 3525957
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum.
Kerr IB; Lee FD; Quintanilla M; Balmain A
Br J Cancer; 1985 Nov; 52(5):695-700. PubMed ID: 3904802
[TBL] [Abstract][Full Text] [Related]
9. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.
Williams AR; Piris J; Spandidos DA; Wyllie AH
Br J Cancer; 1985 Nov; 52(5):687-93. PubMed ID: 3904801
[TBL] [Abstract][Full Text] [Related]
11. Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors.
De Biasi F; Del Sal G; Hand PH
Int J Cancer; 1989 Mar; 43(3):431-5. PubMed ID: 2784420
[TBL] [Abstract][Full Text] [Related]
12. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9.
Allen DC; Foster H; Orchin JC; Biggart JD
J Clin Pathol; 1987 Feb; 40(2):157-62. PubMed ID: 3546394
[TBL] [Abstract][Full Text] [Related]
14. Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions.
Michelassi F; Leuthner S; Lubienski M; Bostwick D; Rodgers J; Handcock M; Block GE
Arch Surg; 1987 Dec; 122(12):1414-6. PubMed ID: 3318757
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study of oncogene-related products in human gastrointestinal malignancies--expression of ras p 21, fes p 85 and EGF receptor].
Kitagami S; Itabashi M; Hirota T; Hayashi I; Hojo K; Moriya Y; Maruyama K; Okabayashi K
Gan No Rinsho; 1986 Dec; 32(15):1950-8. PubMed ID: 2433473
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
[TBL] [Abstract][Full Text] [Related]
17. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
Ward JM; Perantoni AO; Santos E
Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases.
Thor A; Horan Hand P; Wunderlich D; Caruso A; Muraro R; Schlom J
Nature; 1984 Oct 11-17; 311(5986):562-5. PubMed ID: 6482968
[TBL] [Abstract][Full Text] [Related]
19. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.
Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M
Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984
[TBL] [Abstract][Full Text] [Related]
20. [Expression of Ha-ras oncogene product, p21 in gastric carcinoma].
Ebihara T; Koyama S; Osuga T
Nihon Shokakibyo Gakkai Zasshi; 1987 Sep; 84(9):1737-9. PubMed ID: 3323578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
